Healthcare — Institutional Ownership & Hedge Fund Activity
Track hedge fund buying and selling activity in Healthcare stocks based on SEC 13F filings for Q1 2026.
Most Bought Healthcare Stocks
| # | Stock | Company | Funds Buying | Net $ Change |
|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | 0 | +$0 |
| 2 | IMNM | Immunome, Inc. | 0 | +$0 |
| 3 | DOCS | Doximity, Inc. | 0 | +$0 |
| 4 | BEAT | HeartBeam, Inc. | 0 | +$0 |
| 5 | EXAS | Exact Sciences Corporation | 0 | +$0 |
| 6 | FHTX | Foghorn Therapeutics Inc. | 0 | +$0 |
| 7 | LNSR | LENSAR, Inc. | 0 | +$0 |
| 8 | INGN | Inogen, Inc. | 0 | +$0 |
| 9 | AVBP | ArriVent BioPharma, Inc. Common Stock | 0 | +$0 |
| 10 | FBLG | FibroBiologics, Inc. Common Stock | 0 | +$0 |
| 11 | NMRA | Neumora Therapeutics, Inc. Common Stock | 0 | +$0 |
| 12 | CGEM | Cullinan Therapeutics, Inc. | 0 | +$0 |
| 13 | HUMA | Humacyte, Inc. | 0 | +$0 |
| 14 | NVNO | enVVeno Medical Corporation | 0 | +$0 |
| 15 | BGM | BGM Group Ltd. | 0 | +$0 |
| 16 | DSGN | Design Therapeutics, Inc. | 0 | +$0 |
| 17 | BTMD | biote Corp. | 0 | +$0 |
| 18 | CDNA | CareDx, Inc | 0 | +$0 |
| 19 | CRL | Charles River Laboratories International, Inc. | 0 | +$0 |
| 20 | CELC | Celcuity Inc. | 0 | +$0 |
Most Sold Healthcare Stocks
| # | Stock | Company | Funds Selling | Net $ Change |
|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | 0 | +$0 |
| 2 | IMNM | Immunome, Inc. | 0 | +$0 |
| 3 | DOCS | Doximity, Inc. | 0 | +$0 |
| 4 | BEAT | HeartBeam, Inc. | 0 | +$0 |
| 5 | EXAS | Exact Sciences Corporation | 0 | +$0 |
| 6 | FHTX | Foghorn Therapeutics Inc. | 0 | +$0 |
| 7 | LNSR | LENSAR, Inc. | 0 | +$0 |
| 8 | INGN | Inogen, Inc. | 0 | +$0 |
| 9 | AVBP | ArriVent BioPharma, Inc. Common Stock | 0 | +$0 |
| 10 | FBLG | FibroBiologics, Inc. Common Stock | 0 | +$0 |
| 11 | NMRA | Neumora Therapeutics, Inc. Common Stock | 0 | +$0 |
| 12 | CGEM | Cullinan Therapeutics, Inc. | 0 | +$0 |
| 13 | HUMA | Humacyte, Inc. | 0 | +$0 |
| 14 | NVNO | enVVeno Medical Corporation | 0 | +$0 |
| 15 | BGM | BGM Group Ltd. | 0 | +$0 |
| 16 | DSGN | Design Therapeutics, Inc. | 0 | +$0 |
| 17 | BTMD | biote Corp. | 0 | +$0 |
| 18 | CDNA | CareDx, Inc | 0 | +$0 |
| 19 | CRL | Charles River Laboratories International, Inc. | 0 | +$0 |
| 20 | CELC | Celcuity Inc. | 0 | +$0 |
Explore More
Data sourced from SEC 13F filings for Q1 2026. Filings are delayed up to 45 days after quarter end.